This abnormal activation can be attributed to either a germline mutation that leads to the loss of function of the tumor suppressor gene APC in the context of familial adenomatous polyposis (FAP), or somatic mutations occurring in the β-catenin gene (CTNNB1) [25]. Here, APC is linked to Familial adenomatous polyposis.